The government of Bangladesh has approved the emergency use of Pfizer Covid-19 vaccine in the country.
Directorate General of Drug Administration (DGDA) issued a press release in this regard on Thursday.
This is the fourth Covid-19 vaccine approved for emergency use in Bangladesh.
Recently two other vaccines , Sputnik V produced by Generium Joint Stock Company of Russia, and Sinopharm produced by Beijing Institute of Biological Products Co. Ltd of China got approval of DGDA for emergency use in Bangladesh.
Earlier on January 7, DGDA approved the emergency use of Covishield vaccine, also known as SARS Cov-2 AZD1222, Oxford/ Astra zeneca vaccine, produced by Serum Institute of India.
Earlier on May 18, Health Minister Zahid Maleque said that the country will get at least 106,000 doses of the Pfizer vaccine under the Covax facility.
The Pfizer/BioNTech vaccine was the first coronavirus jab to show promising results in the latter stages of its testing process.
It is a new type called an mRNA vaccine that uses a tiny fragment of genetic code from the pandemic virus to teach the body how to fight Covid-19 and build immunity, according to a BBC report.
The US Food and Drug Administration on Wednesday authorized storage of Pfizer Covid-19 vaccine at standard refrigerator temperatures for up to one month, in an effort to make the vaccine more widely available.